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SUMMARY
Defective neutrophils in patients with chronic granulomatous disease (CGD) cause susceptibility 
to extracellular and intracellular infections. As microbes must first be ejected from intracellular 
niches to expose them to neutrophil attack, we hypothesized that inflammasomes detect certain 
CGD pathogens upstream of neutrophil killing. Here, we identified one such ubiquitous 
environmental bacterium, Chromobacterium violaceum, whose extreme virulence was fully 
counteracted by the NLRC4 inflammasome. Caspase-1 protected via two parallel pathways that 
eliminated intracellular replication niches. Pyroptosis was the primary bacterial clearance 
mechanism in the spleen, but both pyroptosis and interleukin-18 (IL-18)-driven natural killer (NK) 
cell responses were required for liver defense. NK cells cleared hepatocyte replication niches via 
perforin-dependent cytotoxicity, whereas interferon-γ was not required. These insights suggested a 
therapeutic approach; exogenous IL-18 restored perforin-dependent cytotoxicity during infection 
by the inflammasome-evasive bacterium Listeria monocytogenes. Therefore, inflammasomes can 
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Inflammasomes are innate immune sensors that detect cytosolic contaminations or 
perturbations. While canonical inflammasomes activate caspase-1, the noncanonical 
inflammasome pathway activates caspase-11. Caspase-1 processes interleukin-1β (IL-1β) 
and IL-18, leading to their secretion, and also triggers a form of programmed lytic cell death 
known as pyroptosis. The NLRC4 inflammasome responds to bacterial type III and IV 
secretion systems (T3SS and T4SS) by specifically detecting three conserved bacterial 
proteins when they are aberrantly translocated into the cytosol of host cells: flagellin, T3SS 
rod, and T3SS needle (Moltke et al. 2013). Like most inflammasomes, NLRC4 must signal 
though the adaptor protein ASC to promote IL-1β and IL-18 secretion. However, unlike the 
PYD-containing inflammasomes (including NLRP3, AIM2, and pyrin) it can also mediate 
pyroptosis directly via CARD-CARD domain interactions with caspase-1 (Moltke et al. 
2013).
Inflammasome-deficient mice are more susceptible to a variety of pathogens, yet the defense 
conferred is typically only incremental. This was perhaps first and most thoroughly 
described for Salmonella typhimurium, which replicates somewhat faster in inflammasome-
deficient mice. The overall effect on the infection is that inflammasome-competent mice die 
two days later than inflammasome-deficient mice (Lara-Tejero et al., 2006; Raupach et al., 
2006). Normalization of death kinetics can be accomplished by only a 4-fold change in the 
infectious dose (Aachoui et al., 2013a; Moltke et al., 2013). Similar or lesser phenotypes are 
observed with Listeria monocytogenes, Yersinia pseudotuberculosis, Y. pestis, Francisella 
novicida, Mycobacterium tuberculosis, Klebsiella pneumoniae, Influenza, and Candida 
albicans (Allen et al., 2009; Fernandes-Alnemri et al., 2010; Gross et al., 2009; Jones et al., 
2012; LaRock and Cookson, 2012; Lightfield et al., 2011; Mayer-Barber et al., 2010; 
Moltke et al., 2013; Sauer et al., 2011; Thomas et al., 2009; Tsuji et al., 2004; Willingham et 
al., 2009). This has led to the conclusion that inflammasomes merely slow the infectious 
process, allowing the host to survive until an adaptive immune response clears the infection.
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Indeed, inflammasomes are ineffective in defense against systemic S. typhimurium and L. 
monocytogenes because these bacteria evade NLRC4, in part by repressing flagellin 
expression (Lara-Tejero et al., 2006; Moltke et al., 2013; Raupach et al., 2006). We 
previously engineered S. typhimurium to express flagellin during systemic infection and 
found that it is completely attenuated in wild-type (WT) mice but remains fully virulent in 
inflammasome-deficient mice. We showed that pyroptosis ejects bacteria from intracellular 
replication niches, exposing them to attack by neutrophils, which kill the bacteria via 
reactive oxygen species (ROS) (Miao et al., 2010a). The extreme efficiency by which the 
innate immune system eradicates evasion-deficient bacteria starkly contrasts with the typical 
role for inflammasomes in vivo as mechanisms to slow, but not halt, WT bacterial 
replication. We therefore hypothesized that there were naturally occurring environmental 
microbes that were analogous to engineered evasion-deficient bacteria. Such microbes 
would almost never cause disease in immune-competent individuals because inflammasome 
detection results in completely penetrant innate immunity.
Although caspase-1-deficient patients have not yet been identified, ROS-deficient patients 
are well studied. Chronic granulomatous disease (CGD) is caused by a variety of germline 
mutations in the genes for NADPH oxidase 2 (NOX2, encoded by Phox) that greatly reduce 
or eliminate ROS production in phagocytes (Holland, 2013). Patients with CGD are 
susceptible to infection by a characteristic array of not only extracellular, but also 
intracellular pathogens (Marciano et al., 2014). In order for neutrophils to attack intracellular 
bacteria, these microbes must first be ejected from their intracellular niche. Thus, we 
hypothesized that a subset of CGD-associated pathogens are detected by inflammasomes 
and released from intracellular niches via pyroptosis. Herein we identified one such 
bacterium, C. violaceum, and used it to reveal unappreciated inflammasome-driven tissue-
specific clearance mechanisms.
RESULTS
Inflammasomes prevent lethal infection by specific CGD pathogens
We performed a survey of five CGD-specific bacteria in inflammasome-deficient mice. 
These were selected based on their inability to infect immunocompetent humans, and the 
bacterial species are further described in Extended Experimental Procedures.
Burkholderia thailandensis is a ubiquitous soil bacterium that uses a T3SS to invade the 
cytosol, where it is detected by caspase-11 (Aachoui et al., 2013a). Consistent with the 
hypothesis that caspase-11-dependent pyroptosis exposes intracellular bacteria to killing by 
neutrophils, mice with the most common form of autosomal recessive CGD (Ncf1−/−, which 
encodes p47phox) were also susceptible to B. thailandensis infection, surviving slightly 
longer than Casp1−/−Casp11−/−mice while WT mice were fully resistant (Figure 1A–B). In 
contrast, species within the related Burkholderia cepacia complex (B. cepacia, B. 
cenocepacia, B. multivorans) that do not encode the T3SS were efficiently cleared by WT 
and Casp1−/−Casp11−/−mice, but were highly virulent in Ncf1−/−mice (Figure 1C and S1A–
D). A similar result was observed for the CGD-tropic pathogens Francisella philomiragia 
(Friis-Moller et al., 2004; Mailman and Schmidt, 2005) and Serratia marcescens (Lee and 
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Lau, 2013; Marciano et al., 2014) (Figure 1D and S1C–F), illustrating that inflammasomes 
were not strictly required for defense against all CGD-tropic pathogens.
Chromobacterium violaceum is a Gram-negative bacterium that derives its name from the 
purple pigment that it produces, called violacin (Durán et al., 2010). C. violaceum is a 
ubiquitous environmental organism that inhabits aquatic environments in the tropics and 
subtropics (Lima-Bittencourt et al., 2010). It encodes two T3SSs, Cpi-1 and Cpi-2, with 
similarity to the S. typhimurium SPI-1 and SPI-2 T3SS, respectively (Brito et al., 2004; Miki 
et al., 2010). Although the natural host that C. violaceum infects is unknown, the Cpi-1 
needle and rod proteins can be detected by the mammalian NLRC4 inflammasome in vitro 
(Yang et al., 2013; Zhao et al., 2011). Most instances of C. violaceum infection in humans 
occur in immune compromised individuals, with 8.5% of cases occurring in confirmed CGD 
patients (Yang and Li, 2011). C. violaceum infection in CGD patients is typified by rapid 
bacteremia often without a nidus of infection, and a 53% mortality rate (Yang and Li, 2011). 
This is experimentally demonstrated in mice, where C. violaceum has minimal virulence for 
WT C57BL/6 mice, while it is highly virulent in Ncf1−/−mice (Segal et al., 2003) (Figure 
1E). We found that like Ncf1−/−mice, Casp1−/−Casp11−/−mice were acutely susceptible to 
C. violaceum infection. As few as 100 CFUs were lethal to Casp1−/−Casp11−/−mice, while 
WT mice survived a challenge of 1,000,000 CFUs (Figure 1E). This susceptibility was 
mirrored by high bacterial burdens in both the liver and spleen in comparison to WT mice, 
which cleared the infection (Figure 1F–I and S1G–J). The exquisite sensitivity of 
Casp1−/−Casp11−/−mice to C. violaceum represents the strongest effect of inflammasomes 
in defense against pathogens in the published literature, equaled only by their susceptibility 
to B. thailandensis (Aachoui et al., 2015).
C. violaceum is liver-tropic in CGD patients (Yang and Li, 2011). Upon examination of 
mice 3 days post infection with 100 CFU of C. violaceum, we observed numerous 
macroscopic lesions on the livers of Casp1−/−Casp11−/−mice (Figure S1K), associated with 
extensive neutrophil infiltration and a complete loss of structure around lesion foci in the 
liver (Figure 1J). These results revealed that certain environmental microbes, such as C. 
violaceum and B. thailandensis, had significant virulence potential that could not be 
contained in the absence of a coordinated action between inflammasomes and phagocyte-
specific NADPH oxidase.
NLRC4 is required for protection against infection by C. violaceum in vivo
The T3SS of C. violaceum can be detected by NLRC4 in vitro (Zhao et al., 2011), but the 
role of NLRC4 during in vivo infection of C. violaceum has not been examined. Therefore, 
we next set out to determine whether the canonical inflammasome pathway (activating 
caspase-1) or the noncanonical inflammasome pathway (caspase-11) was more important for 
defense against C. violaceum. We found that caspase-11 was dispensable for defense, 
whereas Nlrc4−/−Asc−/−mice (which lack all canonical inflammasomes except NLRP1a/1b) 
remained highly susceptible to infection (Figure 2A). ASC is completely required for 
signaling by the PYD-containing inflammasomes, and for the cytokine outputs from NLRC4 
(Wen et al., 2013). However, ASC is dispensable for NLRC4-driven pyroptosis (Miao et al., 
2010a). While ASC-deficient mice had an intermediate susceptibility, NLRC4 was 
Maltez et al. Page 4













absolutely required for resistance to infection (Figure 2B–F and S2A). These results suggest 
a role for pyroptosis and IL-1β and/or IL-18 in defense against C. violaceum.
Differential role for pyroptosis against C. violaceum in the spleen and liver
We next compared caspase-deficient mice to Il1b−/−Il18−/−mice to better understand the 
contributions of pyroptosis and cytokine secretion. Similar to the Asc−/−mice, 
Il1b−/−Il18−/−mice had an intermediate phenotype (Figure 3A–B), again consistent with 
roles for both pyroptosis and cytokines. Interestingly, we observed a different phenotype in 
the spleen, where Il1b−/−Il18−/−mice had few or no bacteria, like WT mice, while 
Casp1−/−Casp11−/−mice carried significant burdens (Figure 3C). This suggested that 
pyroptosis was the primary effector mechanism in the spleen, but that a more complex 
defense mechanism existed in the liver.
IL-18 is protective in the liver whereas IL-1β is dispensable
IL-1β and IL-18 are pleiotropic cytokines that promote innate and adaptive immune 
responses. IL-1β is well known to induce fever, and to potentiate local inflammatory 
responses, resulting in neutrophil influx (Dinarello, 2010). IL-18 was first described as an 
interferon-γ (IFN-γ) stimulating cytokine, and IFN-γ responses are well established to 
promote defense against intracellular pathogens (Souza-Fonseca-Guimaraes et al., 2012). In 
order to study the role of these cytokines in a more penetrant survival challenge, we 
increased the infectious dose to 104 CFUs, resulting in uniform lethality in 
Il1b−/−Il18−/−mice. At this dose, Il18−/−and Asc−/−mice were also highly susceptible to 
infection, while Il1b−/−mice were fully resistant (Figure 3D). In support of this, Asc−/−, 
Il18−/−, and Il1b−/−Il18−/−mice all had elevated bacterial burdens in the liver, but not spleen, 
in comparison to WT and Il1b−/−mice (Figure 3E–F and S3A–B). These results further 
supported our hypothesis that pyroptosis was the primary defense mechanism against C. 
violaceum in the spleen, and revealed that IL-18, but not IL-1β, was protective in the liver.
Natural killer cell cytotoxicity is required to clear intracellular replication niches
In considering IL-18 responsive cell types, we found that NK cells have higher IL-18R 
expression than any other cell type or organ (Figure S4A). Accordingly, depletion of NK 
and NKT cells from WT mice resulted in elevated bacterial burden in the liver, but not the 
spleen (Figure 4A–B). As IL-18 secretion drives IFN-γ production in natural killer (NK) 
cells and certain T cells (Chaix et al., 2008), and because IFN-γ is well established as a 
potent cytokine in defense against intracellular pathogens (Adib-Conquy et al., 2013; Le-
Barillec et al., 2005; Souza-Fonseca-Guimaraes et al., 2012), we hypothesized that IFN-γ 
would be the primary effector mechanism downstream of IL-18. Surprisingly, this was not 
the case, as Ifng−/−mice had bacterial burdens comparable to those seen in WT mice (Figure 
4C–D).
We then considered whether the predominance of IL-18 for liver but not splenic defense was 
in part due to the differences in cell populations between the liver and spleen. The spleen is 
primarily composed of macrophages, T cells, B cells, and dendritic cells. In contrast, 80–
90% of the liver is composed of hepatocytes, with the remainder composed of Kupffer cells 
(liver resident macrophages), NK cells, and other immune cells (Grégoire et al., 2007). 
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Thus, when considering target cells that C. violaceum may infect, the liver is dramatically 
different from the spleen. Interestingly, primary hepatocytes did not express detectable 
amounts of caspase-1 after LPS stimulation (Figure 4E). In contrast, splenocytes expressed 
abundant caspase-1 (Figure 4E), as do liver mononuclear cells (Petrasek et al., 2012). This 
may explain why pyroptosis appears to be sufficient to defend the spleen, but not the liver. 
Indeed, hepatocytes contained 90% of the C. violaceum bacterial burden in the liver (Figure 
4F), and C. violaceum also efficiently infected primary hepatocytes in vitro (Figure 4G). 
However, consistent with the lack of caspase-1 expression, we did not observe appreciable 
lytic cell death in infected primary hepatocytes (Figure 4H and S4D). In contrast, rapid and 
robust caspase-1/11-dependent lytic cell death was observed in liver immune cells and 
splenocytes (Figure 4H). Consequently, we hypothesized that a cell death pathway parallel 
to pyroptosis was required to eject the bacteria from their replicative niche in hepatocytes, 
and expose them to neutrophil killing.
Previous studies show that exposure to IL-18 can prime the cytotoxic effects of NK and 
NKT cells in addition to promoting IFN-γ production (Dao et al., 1998; Son et al., 2001). 
These cytotoxic effects require perforin, a pore-forming protein that NK/NKT and cytotoxic 
T lymphocytes (CTLs) use to kill target cells (Kägi et al., 1994; Lopez et al., 2013). 
However, while NK and/or NKT cell cytotoxic activity is a well-established antiviral 
effector mechanism (Shabani et al., 2014), it has not been established as an important 
defense mechanism against intracellular bacteria. For example, WT and Prf1−/−mice had 
similar bacterial burdens after infection with the model intracellular pathogens L. 
monocytogenes or S. typhimurium (Figure 4I–J and S4B–C). However, interpretation of 
these results were confounded by the fact that both L. monocytogenes and S. typhimurium 
largely evade NLRC4 in vivo (Miao et al., 2010a; Sauer et al., 2011), thereby minimizing 
IL-18 secretion. Nevertheless, we examined whether perforin has a role in defense against 
C. violaceum, which was readily detected by NLRC4 in vivo. Both Prf1−/− and 
Casp1−/−Casp11−/−mice had significantly higher bacterial burdens than WT and 
Ifng−/−mice in the liver, but again, only Casp1−/−Casp11−/−mice had substantial bacterial 
burdens in the spleen (Figure 4K–L and S4E–F). These results indicated that NK and/or 
NKT cells were protective in the liver but were dispensable for splenic clearance (where 
pyroptosis was sufficient), and suggested that their cytotoxic activity as the primary 
protective mechanism.
The adaptive immune system is dispensable for defense against C. violaceum
Several cell types express perforin, including NK cells, NKT cells, and CTLs (Kägi et al., 
1994; Lopez et al., 2013). To determine whether NKT cells and/or CTLs, were required for 
resistance to C. violaceum, we examined Rag1−/−mice, which lack all B and T cells. 
Interestingly, Rag1−/−and WT mice had similar bacterial burdens and clearance kinetics 
(Figure 5A–B), demonstrating that neither NKT cells nor CTLs were the primary cytotoxic 
effector cells against C. violaceum infection. Additionally, we concluded that 
inflammasomes provided innate immunity against this ubiquitous environmental microbe 
that did not require an adaptive immune response.
Maltez et al. Page 6













IL-18 administration improves NK cell recruitment and cytotoxicity in vivo
We hypothesized that a lack of IL-18 in inflammasome-deficient mice prevented appropriate 
recruitment and/or stimulation of NK cells, so we examined whether administration of 
exogenous IL-18 could restore NK cell function. IL-18 therapy resulted in significantly 
reduced bacterial burdens in Casp1−/−Casp11−/−and Il1b−/−Il18−/−mice (Figure 6A–B). 
However, because exogenous IL-18 did not fully normalize bacterial burdens in 
Il1b−/−Il18−/−mice, it was likely that IL-18 therapy could be further optimized from a 
pharmacologic standpoint. To examine the response of NK cells to IL-18, we performed 
flow cytometry on liver immune cells isolated from untreated and IL-18-treated 
Nlrc4−/−Asc−/−mice. IL-18 therapy promoted a three-fold increase in conventional NK cell 
numbers, but no increase of liver resident NK cells and NK1.1+CD3+ cell (likely NKT cells) 
numbers (Figure 6C–D and S5A). Granzyme B is a serine protease that is secreted from NK 
cells and CTLs along with perforin to mediate target cell death, and is an established marker 
for cyotolytic activation of these cell types. Notably, we saw increased granzyme B mean 
fluorescence intensity (MFI) in conventional NK cells, but no significant increase in the 
MFI of liver resident NK or NKT cells (Figure 6E and S5B). These results were consistent 
with the lack of phenotype in Rag1−/−mice (Figure 5), and suggested that IL-18 was driving 
both NK cell recruitment to infected target organs and increased activation.
Our model thus far suggested that pyroptosis was the primary defense mechanism in the 
spleen, while IL-18 drove defense in the liver. Thus, the observation that IL-18 treatment 
was therapeutic in the spleen of Casp1−/−Casp11−/−mice was unexpected (Figure 6B). 
However, Casp1−/−Casp11−/−mice are deficient for both pyroptosis and IL-18 in the spleen, 
therefore, pyroptosis and NK cytotoxicity could be independently sufficient to prevent 
bacterial colonization in the spleen. Unfortunately, pyroptosis-deficient mice have not been 
developed, so we cannot directly assess whether endogenous IL-18 would be sufficient in 
the absence of pyroptosis.
We next sought to provide evidence that IL-18 therapy acts through NK cells. Consistent 
with our findings, Nlrc4−/−Asc−/−mice were highly susceptible to C. violaceum infection, 
and bacterial clearance could be rescued by IL-18 therapy (Figure 6F). However, when 
simultaneously depleted of NK cells, IL-18 therapy failed. Further, IL-18 therapy also 
required cytotoxic activity, as Prf1−/−mice failed to respond (Figure 6G). Therefore, IL-18 
acted upstream of NK cell cytotoxic activity against intracellular bacterial infection in vivo.
In order to demonstrate that C. violaceum infected hepatocytes can be killed by NK cells, we 
combined ex vivo and in vitro techniques. Hepatocytes were isolated from C. violaceum-
infected Ncf1−/−mice, which carried huge bacterial burdens in their liver. These were used 
as target cells for lysis by liver immune cells harvested from infected WT mice (Figure 6H). 
We observed hepatocyte killing that was ablated by NK cell depletion. Furthermore, 
hepatocyte killing increased with cells from IL-18 treated mice (Figure 6H). In summation, 
NK cells killed hepatocytes in vitro, and this killing was enhanced with IL-18 therapy, 
consistent with our in vivo results (Figure 6).
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Exogenous IL-18 is therapeutic against L. monocytogenes
Our observations revealed a unique link between inflammasomes and NK cell cytotoxicity 
in defense against a ubiquitous intracellular environmental bacterium, so we sought to 
discover if this mechanism was applicable to a bona fide human pathogen. Like C. 
violaceum, L. monocytogenes is well established to infect hepatocytes (Cousens and Wing, 
2000). However, unlike C. violaceum, L. monocytogenes evades inflammasome detection. 
Therefore, we examined the efficacy of IL-18 treatment during L. monocytogenes infection. 
Bacterial burdens were significantly decreased in the liver and spleen of IL-18 treated WT 
mice (Figure 7A–B), but there was no difference between untreated and treated Prf1−/−mice 
in the liver (Figure 7A). Splenic burdens were decreased in Prf1−/−mice upon IL-18 therapy 
(Figure 7B), suggesting that there were also perforin-independent mechanisms of clearing 
the spleen, perhaps through IFN-γ. Importantly, despite the increased susceptibility of 
Ifng−/−mice to L. monocytogenes infection, IL-18 therapy was still beneficial to these mice 
(Figure 7C–D). Moreover, IL-18 therapy was still effective in Rag−/−mice, indicating that 
IL-18 acted independently of the adaptive immune system, as it did during C. violaceum 
infection (Figure 7E–F). Thus, perforin-dependent cytotoxicity against intracellular bacteria 
was a bona fide defense mechanism downstream of IL-18 secretion that was 
underappreciated due to the ability of many bacteria, such as L. monocytogenes, to evade 
inflammasome detection in vivo.
DISCUSSION
While inflammasomes are appreciated to be an innate immune mechanism that slows the 
course of infection, prevailing published evidence indicates that inflammasomes ultimately 
fail to eradicate pathogens. However, studies using bacteria engineered to remove 
inflammasome evasion hint at the converse hypothesis: that inflammasomes have the 
unrealized capacity of directing sterilizing immunity (Miao et al., 2010a; 2010b; Sauer et al., 
2011). We propose that the importance of inflammasomes during infection is 
underappreciated because phenotypes have been interpreted in the face of confounding 
pathogenic evasion strategies. We further propose that animals are constantly exposed to a 
milieu of highly virulent environmental microbes that have remained uncharacterized 
because inflammasomes completely prevent disease in immunocompetent individuals. It is 
important to note that under our model, inflammasomes would be unimportant against 
environmental microbes that do not encode such potent virulence traits.
Concordantly, C. violaceum and B. thailandensis are ubiquitous water and soil bacteria that 
rarely cause infection in humans, despite the fact that they encode potent virulence traits, 
including T3SSs that enable intracellular replication or cytosolic invasion (Wiersinga et al., 
2006; Yang and Li, 2011). Our results herein show that inflammasomes detect these 
virulence traits, and initiate a specific innate immune defense program that provides 
sterilizing innate immunity. To our knowledge, the role of inflammasomes in defense 
against C. violaceum (shown here) and B. thailandensis (Aachoui et al., 2015) are the most 
penetrant inflammasome phenotype against any infection, be it bacterial, viral, fungal, or 
parasitic. We hypothesize that this is one example of a wide array of potentially lethal 
environmental microbes. Exposure to such microbes might exert a strong evolutionary 
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pressure that could explain the maintenance and expansion of inflammasome genes. We 
propose that if people lacked NLRC4, swimming in freshwater lakes or streams might carry 
an incredible risk of death subsequent to infection by C. violaceum.
Why should we be interested in studying bacteria to which almost all people are innately 
immune? The answer lies in the fact that these bacteria offer us the opportunity to study the 
innate immune system in its fully functional state, unobscured by pathogenic evasion 
strategies. Our studies of C. violaceum reveal the importance of inflammasomes in driving 
parallel mechanisms to clear intracellular replication niches. Pyroptosis appears to be fully 
competent to protect the spleen, where inflammasome-expressing macrophages are 
abundant. This likely occurs in liver macrophages as well. It should be noted that we have 
not provided definitive evidence that pyroptosis is the mechanism of clearance in the spleen; 
our data address 4 of 7 criteria that we have previously described (Aachoui et al., 2013b). A 
rapid pyroptotic response in the early hours of infection is thus predicted to eliminate the 
bacteria before they can replicate to high numbers. In addition to pyroptosis, inflammasome-
driven IL-18 primes NK cells to kill infected hepatocytes in the liver, providing an example 
where NK cell cytotoxicity is critical to bacterial clearance in vivo.
The two primary effector mechanisms used by NK cells are production of IFN-γ and 
cytotoxicity. NK cell cytotoxicity, a well-established mechanism against viral pathogens, is 
not established in defense against bacterial pathogens in vivo (Souza-Fonseca-Guimaraes et 
al., 2012). There are numerous studies that demonstrate NK cell cytotoxicity in vitro against 
bacterially infected cells (Katz et al., 1990; Souza-Fonseca-Guimaraes et al., 2012), yet 
these responses were later found to be ineffective during infection in vivo (Junqueira-Kipnis 
et al., 2003; Souza-Fonseca-Guimaraes et al., 2012), likely because of pathogenic evasion 
strategies. We identified cytotoxicity, instead of IFN-γ, as the NK effector mechanism 
employed against C. violaceum infected hepatocytes in vivo. L. monocytogenes is also 
highly tropic for hepatocytes, yet NK cell cytotoxicity fails to clear this infection (Cousens 
and Wing, 2000). We propose that this is due to inflammasome evasion strategies employed 
by L. monocytogenes in vivo, whereby IL-18 secretion is limited (Sauer et al., 2011). Here 
we used IL-18 therapy as an innate immune booster to harness NK cytotoxicity and 
specifically eliminate L. monocytogenes-infected cells in the innate phase of infection.
Therefore, when we study bona fide pathogens, it is difficult to distinguish between innate 
immune mechanisms that are simply not useful from those that are actively evaded. The 
latter could be harnessed therapeutically to combat the infection, and environmental bacteria 
like C. violaceum and B. thailandensis may be the key to uncovering such insights. We used 
the well-studied susceptibility of CGD patients to identify extremely virulent bacteria that 
are normally cleared by the innate immune system with exquisite efficiency. It is likely that 
other environmental microbes, in a similar fashion, will inform our understanding of 
previously underappreciated innate immune clearance mechanisms. These microbes provide 
a lens with which to understand the capabilities of the innate immune system when it is 
correctly activated, acting as powerful tools to help develop therapeutics that bypass the 
evasion strategies of bona fide pathogens.
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Bacterial strains and growth conditions
The following strains were used in this work: C. violaceum (ATCC 12472), S. typhimurium 
(CS401), L. monocytogenes (10403s; kind gift from D.A.P.), and B. thailandensis (passaged 
through Casp1−/−Casp11−/−mouse strain). Additionally, the following strains were isolated 
from CGD patients (by S.M.H.): B. cepacia, B. multivorans, B. cenocepacia, F. 
philomiragia, and S. marcescens.
S. typhimurium and all Burkholderia species were grown in Luria-Bertani medium (LB). C. 
violaceum, S. marcescens, and L. monocytogenes were grown in Brain heart infusion (BHI). 
F. philomiragia was grown in BHI + isovitalex. All strains were grown overnight at 37°C 
and back-diluted (1:40) for 2 hours in their respective media for use in both in vitro and in 
vivo experiments.
Mouse infections
Mouse strain information and housing conditions are described in the Extended 
Experimental Procedures. For all mouse infections, 8–12 week old mice were infected with 
the designated colony forming units (Cfu) of log phase bacteria in PBS by intraperitoneal 
(IP) injection. Livers and spleens were harvested at the indicated time point (3, 4, 10, or 21 
days post infection), homogenized and dilutions plated on LB or BHI as described above. 
For NK cell depletion, mice were injected IP with 75 μg anti-NK1.1 PK136 or isotype 
control C1.18.4 (BioXCell) at -3 and -1 dpi. Depletion of NK1.1-positive cells was 
confirmed by flow cytometry. For IL-18 therapies, mice were injected IP with 0.2 μg 
recombinant mouse IL-18 (rmIL-18; MBL) at the time of infection, 24, and 48 hpi (C. 
violaceum infections), or 24, 48, and 72 hpi (L. monocytogenes infections).
Histology
Livers and spleens were fixed in formalin and embedded in paraffin to generate section of 5 
μm thickness. Paraffin sections were counterstained with hemotoxylin and eosin.
Cell isolation
A detailed protocol is in the Extended Experimental Procedures. In brief, livers were 
extracted, perfused with Collagenase D, mashed through a cell strainer (Falcon), and washed 
with DMEM. Cells were spun and the supernatant removed. Pellets were resuspended in 
44% Percoll (GE Healthcare) in DMEM and under laid with 66% Percoll. Cells were spun at 
2,000 x g and the hepatocytes were harvested from the upper layer. Lymphocytes were 
treated with RBC lysis buffer, spun, the supernatant removed, and the pellet resuspended in 
DMEM or 1X PBS depending on usage. Splenocytes were harvested in the same manner but 
without the Percoll gradient. Average hepatocyte purity as assessed by CD45 staining was 
determined to be 99.5%. Average liver immune cell purity as assessed visually by 
hemacytometer counting was determined to be >99.5%.
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For Western blots, total protein from lysates of 5 × 104 hepatocytes or splenocytes was 
analyzed. Caspase-1 expression was determined using an anti-caspase-1 antibody (clone 
4B4, Genentech). Blots were stripped and equivalent loading of protein was ensured by 
Western blot using anti-β-actin HRP antibody (Cat. # 20272, AbCam) diluted 1:20,000.
Bacterial count enumeration
For percentages of intracellular C. violaceum in vivo, equal weights of livers were 
harvested. Total cfu were obtained from one section, cfu specific to the hepatocyte fraction 
from the second section via the cell isolation technique, and the hepatocyte cfu graphed as a 
percentage of the total. For percentages of intracellular C. violaceum in vitro, hepatocytes 
were isolated, seeded in a 96 well plate, and allowed to rest for 2 hours. C. violaceum were 
grown to log phase and hepatocytes were infected at an MOI of 25, with Gentamicin (5 
ng/ml) added 30 min p.i. At 1, 2, 3, and 4 hours post infection, intracellular bacterial burden 
was determined by plating cell lysates on BHI.
Flow cytometry
For flow preparation, cells were Fc-blocked with anti-CD16/CD32 and stained with anti-
CD45-PercPCy5.5 (104), NK1.1-FITC (PK136), CD3, Granzyme B, and the cell viability 
marker Aqua dead live-AmCyan, all from BD. Cells were fixed in 2% PFA and samples 
were analyzed on a Becton Dickinson LRSIII (HTS) (UNC Flow Cytometry Core Facility).
Assessment of NK killing in vitro
Hepatocytes were harvested from Ncf1−/−mice 17 hpi with 100 Cv. Liver immune cells were 
harvested from WT mice under 3 conditions 48 hpi. (1–2) WT mice were treated with 
isotype or anti-NK1.1 antibody days 1 and 3 prior to infection with 104 Cv. (3) WT mice 
were infected with 104 Cv and treated with 0.2 μg rm IL-18 at the time of infection and 24 
hours later. Hepatocytes and immune cells were seeded into 96 well plates and allowed to 
rest for 2 hours. Non-adherent immune cells were used to enrich for NK cells. The 
hepatocytes and immune cells were then coincubated at an effector: target ratio (E:T) of 
50:1 and cell death was evaluated 6 hours later. LDH release was defined as 
(LDHEXPERIMENTAL – LDHEFFECTORS – LDHSPONTANEOUS)/(LDHMAXIMAL – 
LDHSPONTANEOUS), where LDHEFFECTOR refers to the liver immune cells, 
LDHSPONTANEOUS refers to hepatocytes, and LDHMAXIMAL refers to total lysis of 
hepatocytes by Triton X-100.
Statistics
Error bars represent the standard deviation of technical replicates. A standard two-tailed 
unpaired t-test (Prism 5; GraphPad) was used for statistical analysis, wherein P values of ≤ 
0.05 were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Inflammasomes and the NADPH oxidase are required to clear specific CGD pathogens
(A–D) Mice were infected IP with (A) 2×107 or (B) 1×104 cfu of B. thailandensis, (C) 
1×106 cfu of B. cepcacia, (D) or 1×106 cfu of F. philomiragia and monitored for survival. 
Casp1−/−Casp11−/−mice referred to as Casp1-11DKO. Mice: (A) WT=9, Casp1-11DKO=10, 
Ncf1−/−=10; (B) WT=4, Casp1-11DKO=6, Ncf1−/−=9; (C) n=4 for all; (D) n=5 for all.
(E) Mice were infected IP with C. violaceum (Cv) at the indicated doses and monitored for 
survival. Mice: WT=4, Casp1-11DKO=7, Ncf1−/−=4.
(F–I) Mice were infected IP with 100 cfu of Cv and bacterial burdens were measured in the 
liver and spleen (F–G) 72 hours later or (H–I) 17 hours later.
(J) Mice were infected IP with 100 cfu of Cv and 72 hours later livers and spleens were 
embedded in paraffin and H&E stained.
Data and statistical analyses are representative of at least two experiments (A–D, H–I), three 
experiments (F–G), or pooled from two experiments (E). Dashed line: limit of detection. * p 
≤ 0.05; survival curve analysis (A–E), two-tailed unpaired t-test (F–I). See also Supp Figure 
1.
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Fig. 2. Canonical inflammasome signaling via NLRC4 prevents lethal infection by C. violaceum 
in vivo
(A–B) Mice were infected IP with 100 cfu of Cv and monitored for survival. 
Nlrc4−/−Asc−/−mice referred to as Nlrc4-AscDKO. Mice: (A) Casp1-11DKO=4, Nlrc4-AscDKO 
=4, Casp11−/−=5; (B) n=4 for all.
(C–F) Mice were infected IP with 100 cfu of Cv, and bacterial burdens were measured in 
livers and spleens 72 hours later.
All data and statistical analyses are representative of at least three experiments. * p ≤ 0.05; 
survival curve analysis (A–B) two-tailed unpaired t-test (C–F). See also Supp Figure 2.
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Fig. 3. Differential role for pyroptosis in the liver and spleen
(A and D) Mice were infected with Cv at the indicated doses and monitored for survival. 
Il1b−/−Il18−/−mice referred to as Il1b-Il18DKO. Mice: (A) Casp1-11DKO=5, Il1b-Il18DKO 
=7, Il1b−/−=5; (D) Il1b-Il18DKO =5, Il1b−/−=5, Il18−/−=4, Asc−/−=5.
(B–C and E–F) Mice were infected IP with 100 cfu of Cv and bacterial burdens were 
measured in livers and spleens 72 hours later.
Data and statistical analyses are representative of at least two experiment (A and D–F) or 
three experiments (B–C), or pooled from two experiments (E–F). * p ≤ 0.05; survival curve 
analysis (A and D), two-tailed unpaired t-test (B–C and E–F). * over a line indicates that all 
data sets under the line have p ≤ 0.05 for each pair wise comparison possible. See also Supp 
Figure 3.
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Fig. 4. Cytotoxic activity of NK cells is required for clearance of C. violaceum
(A–D and K–L) Mice were infected IP with Cv at the indicated doses and bacterial burdens 
were measured in livers and spleens 72 hours later. (A–B) Mice were injected IP with 75 μg 
of isotype or anti-NK1.1 antibody at 1 and 3 days prior to infection.
(E) Primary hepatocytes and splenocytes from naïve WT mice were treated with LPS, lysed, 
and examined for caspase-1 via Western blot.
(F) Mice were infected IP with 100 cfu of Cv and bacterial burdens were measured in livers 
72 hours later. Equal weight liver sections were removed and the hepatocyte fraction was 
graphed as a percentage of the total burden by weight.
(G) Primary hepatocytes were infected with Cv at an MOI of 25 and percentage of invasive 
bacteria was determined via gentamycin protection assay
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(H) Primary hepatocytes, liver immune cells, and splenocytes were infected with Cv at an 
MOI of 10, treated with gentamycin, and LDH release was determined (note, different 
splenocytes have a distinct LDH content per cell, thus in this case LDH release does not 
directly translate to percent lysis).
(I–J) Mice were infected IP with 103 cfu of L. monocytogenes (Lm) and bacterial burdens 
were measured in livers and spleens 72 hours later.
Data and statistical analyses are representative of two experiments (C–D and I–J) or pooled 
from two (K–L) or three experiments (A–B). * p ≤ 0.05; two-tailed unpaired t-test (A–D and 
I–L). See also Supp Figure 4.
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Fig. 5. Adaptive immune responses are not required for sterilizing immunity against C. 
violaceum
(A–B) Mice were infected IP with 103 cfu of Cv and bacterial burdens were measured in 
livers and spleens at the indicated times.
Data and statistical analyses are representative of two experiments. * p ≤0.05; two-tailed 
unpaired t-test.
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Fig. 6. Exogenous IL-18 recruits NK cells and primes their cytotoxic effects
(A–G) Mice were infected IP with 100 cfu of Cv and (A–B and F–G) bacterial burdens were 
measured in livers and spleens 72 hours later. (A–B and F) Mice were injected IP with PBS 
or recombinant mouse IL-18 (0.2 μg/dose at 0, 24, and 48 hours). (F) Mice were injected IP 
with 75 μg of isotype or anti-NK1.1 antibody at 1 and 3 days prior to infection. (C–E) Liver 
immune cells were collected and prepared for flow cytometry 1 day post infection. Markers 
for conventional NK (NK1.1hiDX5+), liver resident NK (NK1.1hi, DX5 ), and (likely) NKT 
(NK1.1+DX5 CD3+) cell populations were determined in addition to granzyme B staining.
(H) Hepatocytes were harvested from Ncf1−/−mice infected with 100 Cv 17 hpi. Liver 
immune cells were harvested from WT mice infected with 104 Cv under 3 conditions: 
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isotype antibody treatment, anti-NK1.1 antibody treatment, or IL-18 therapy. Cells were 
coincubated in a 96 well plate and hepatocyte killing was determined by LDH assay 6 hours 
later. A model of the experimental setup is provided.
Data and statistical analyses are representative of at least two experiments (A–E, F), or 
pooled from two experiments (F).
* p ≤ 0.05; two-tailed unpaired t-test (A–B and D–H). See also Supp Figure 5.
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Fig. 7. L. monocytogenes burdens are reduced upon IL-18 administration
(A–F) Mice were infected IP with 103 cfu of Lm and injected IP with PBS or recombinant 
mouse IL-18 (24, 48 and 72 hours), and bacterial burdens were measured in livers and 
spleens 4 days later. Data and statistical analyses are pooled from two experiments (A–F). * 
p ≤ 0.05; two-tailed unpaired t-test (A–F).
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